BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26184844)

  • 1. RNF43 Inhibits Cancer Cell Proliferation and Could be a Potential Prognostic Factor for Human Gastric Carcinoma.
    Niu L; Qin HZ; Xi HQ; Wei B; Xia SY; Chen L
    Cell Physiol Biochem; 2015; 36(5):1835-46. PubMed ID: 26184844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway.
    Gao Y; Cai A; Xi H; Li J; Xu W; Zhang Y; Zhang K; Cui J; Wu X; Wei B; Chen L
    Stem Cell Res Ther; 2017 Apr; 8(1):98. PubMed ID: 28446252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.
    Neumeyer V; Grandl M; Dietl A; Brutau-Abia A; Allgäuer M; Kalali B; Zhang Y; Pan KF; Steiger K; Vieth M; Anton M; Mejías-Luque R; Gerhard M
    Carcinogenesis; 2019 Jun; 40(4):551-559. PubMed ID: 30380024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
    Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
    Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
    Yu W; Ma S; Wang L; Zuo B; Li M; Qiao Z; Pan X; Liu Y; Wang J
    Histol Histopathol; 2013 Dec; 28(12):1629-38. PubMed ID: 23836308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF43 interacts with NEDL1 and regulates p53-mediated transcription.
    Shinada K; Tsukiyama T; Sho T; Okumura F; Asaka M; Hatakeyama S
    Biochem Biophys Res Commun; 2011 Jan; 404(1):143-7. PubMed ID: 21108931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
    Wei B; Huang QY; Huang SR; Mai W; Zhong XG
    Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers.
    Jo YS; Kim MS; Lee JH; Lee SH; An CH; Yoo NJ
    Hum Pathol; 2015 Nov; 46(11):1640-6. PubMed ID: 26297255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
    Eto T; Miyake K; Nosho K; Ohmuraya M; Imamura Y; Arima K; Kanno S; Fu L; Kiyozumi Y; Izumi D; Sugihara H; Hiyoshi Y; Miyamoto Y; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Furukawa T; Araki K; Baba H; Ishimoto T
    J Pathol; 2018 Aug; 245(4):445-455. PubMed ID: 29756208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
    Zhang S; Li L; Lin JY; Lin H
    World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
    Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
    Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
    Min BH; Hwang J; Kim NK; Park G; Kang SY; Ahn S; Ahn S; Ha SY; Lee YK; Kushima R; Van Vrancken M; Kim MJ; Park C; Park HY; Chae J; Jang SS; Kim SJ; Kim YH; Kim JI; Kim KM
    J Pathol; 2016 Nov; 240(3):304-314. PubMed ID: 27514024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognosis of MYOZ2 in gastric cancer.
    Li YF; Zhu GY; Ma Y; Qu HY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5920-5927. PubMed ID: 30280773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
    Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocadherin 7 inhibits cell migration and invasion through E-cadherin in gastric cancer.
    Chen HF; Ma RR; He JY; Zhang H; Liu XL; Guo XY; Gao P
    Tumour Biol; 2017 Apr; 39(4):1010428317697551. PubMed ID: 28381163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.